MiR-204 reduces cisplatin resistance in non-small cell lung cancer through suppression of the caveolin-1/AKT/Bad pathway.
Aging (Albany NY)
; 11(7): 2138-2150, 2019 04 12.
Article
in En
| MEDLINE
| ID: mdl-30981205
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cisplatin
/
Carcinoma, Non-Small-Cell Lung
/
MicroRNAs
/
Caveolin 1
/
Lung Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Aging (Albany NY)
Journal subject:
GERIATRIA
Year:
2019
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos